GuerbetXPAR:GBT -0.54%69 OCF Margin % is 14.37% as of Dec. 2025, which is 50% above its 10-year median of 9.61. GuruFocus rates XPAR:GBT with a GF Score™ of 69/100 and a GF Value™ of €19.65 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Guerbet ranks better than 58.16% on this metric.
The historical rank and industry rank for Guerbet's OCF Margin % or its related term are showing as below:
XPAR:GBT'
s OCF Margin % Range Over the Past 10 Years
Min: 3.45 Med: 9.61 Max: 16.8
Current: 10.15
During the past 13 years, the highest OCF Margin % of Guerbet was 16.80%. The lowest was 3.45%. And the median was 9.61%.
XPAR:GBT's OCF Margin % is ranked better than 58.16% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs XPAR:GBT: 10.15
Guerbet OCF Margin % Related Terms
Guerbet OCF Margin % Historical Data
* Premium members only.
The historical data trend for Guerbet's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:GBT vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Guerbet's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guerbet OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guerbet's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Guerbet's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guerbet (XPAR:GBT) has a OCF Margin % of 14.37% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guerbet and its competitors. This is 50% above median its historical median of 9.61. Over the past decade, Guerbet's OCF Margin % has ranged from 3.45 to 16.80. According to the industry distribution chart, Guerbet ranks #341 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 41.8%.
Is Guerbet's OCF Margin % too high?
Guerbet's current OCF Margin % of 14.37% is 50% above median its 10-year median of 9.61. Over the past 10 years, this metric has ranged from a low of 3.45 to a high of 16.80. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Guerbet's value of 14.37% is 145.2% above this industry median. Based on the distribution chart, Guerbet ranks #341 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Guerbet has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Guerbet's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Guerbet ranks #341 out of 815 companies for OCF Margin %. This puts Guerbet in the upper half of its industry. The industry median OCF Margin % is 5.86. Guerbet's value of 14.37% is 145.2% above this benchmark. Historically, Guerbet's own OCF Margin % has ranged from 3.45 to 16.80 over the past decade. While the company's 10-year median is 9.61 vs. the industry median of 5.86, Guerbet has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guerbet's current OCF Margin % of 14.37% is 145.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guerbet and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guerbet's current OCF Margin % is 14.37%, which is 50% above median its own 10-year median of 9.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guerbet stock overvalued right now?
Based on GuruFocus' analysis, Guerbet (XPAR:GBT) is currently considered Possible Value Trap. The stock's GF Value™ is €19.65, compared to a current price of €9.18 — trading 53.3% below its estimated fair value. The current OCF Margin % is 14.37%, which is 50% above median its 10-year median of 9.61 and 145.2% above the Medical Devices & Instruments industry median of 5.86. Guerbet's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Guerbet (XPAR:GBT), the current OCF Margin % is 14.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guerbet (XPAR:GBT) Overvalued in 2026?
Based on GuruFocus' analysis, Guerbet stock appears to be undervalued.
The current stock price of €9.18 is trading 53.3% below its estimated GF Value™ of €19.65.
GuruFocus considers Guerbet to be Possible Value Trap.
Key valuation signals for XPAR:GBT:
OCF Margin %: 14.37% (50% above median its 10-year median of 9.61)
GF Value™: €19.65 vs. price of €9.18 (53.3% below fair value)
Industry Position: 145.2% above the Medical Devices & Instruments median (#341 of 815)
No single metric tells the full story. See the XPAR:GBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
69GF Score
Get the complete analysis for XPAR:GBT
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:GBT has been successfully added to your 
